Ritonavir Export Market Intelligence: India's 84 Suppliers Shipping to 155 Countries — TransData Nexus 2026

Q: Who are the top ritonavir exporters from India?

The top ritonavir exporters from India are: 1. HETERO LABS LIMITED — $193.8M (56.9% market share); 2. MYLAN LABORATORIES LIMITED — $92.0M (27.0% market share); 3. CIPLA LIMITED — $24.1M (7.1% market share); 4. EMCURE PHARMACEUTICALS LIMITED — $15.2M (4.5% market share); 5. AUROBINDO PHARMA LTD — $4.9M (1.4% market share). Together they account for 96.9% of India's total ritonavir export value.

Q: What is the total export value of ritonavir from India?

The total export value of ritonavir from India is $340.6M USD, recorded across 1,555 shipment transactions from 84 active exporters to 155 destination countries. The average shipment value is $219.0K.

Q: Which countries import ritonavir from India?

India exports ritonavir to 155 countries worldwide. The top importing countries are: BELGIUM (51.5% share, $175.4M), INDONESIA (7.8% share, $26.6M), VIETNAM (6.3% share, $21.3M), RWANDA (4.9% share, $16.5M), SOUTH AFRICA (3.7% share, $12.7M). These five markets account for 74.1% of total export value.

Q: What is the HS code for ritonavir exports from India?

The primary HS code for ritonavir exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of ritonavir exports from India?

The average unit price for ritonavir exports from India is $20.57 USD per unit, with prices ranging from $0.00 to $2500.00 depending on formulation, packaging, and order volume. The total market is valued at $340.6M across 1,555 shipments.

Q: Which ports handle ritonavir exports from India?

The primary ports for ritonavir exports from India are SAHAR AIR (21.5% of shipments), SAHAR AIR CARGO ACC (INBOM4) (18.1% of shipments), HYDERABAD ACC (INHYD4) (14.0% of shipments), HYDERABAD AIR (7.9% of shipments), Bombay Air (5.6% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of ritonavir?

India is one of the world's leading exporters of ritonavir due to its large base of 84 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports ritonavir to 155 countries, demonstrating 79% global market coverage.

Q: What certifications do Indian ritonavir exporters need?

Indian ritonavir exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import ritonavir from India?

There are 525 registered buyers importing ritonavir from India, spread across 155 countries. The repeat buyer rate is 47.2%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top ritonavir supplier from India?

HETERO LABS LIMITED is the leading ritonavir exporter from India with a market share of 56.9% and total export value of $193.8M across 494 shipments. The top 5 suppliers together control 96.9% of total export value.

Suresh Sormare

Ritonavir

India Pharmaceutical Trade Intelligence

$340.6M84 Suppliers155 CountriesHS 30049099

ExportsIndia → BELGIUM51.5%India → INDONESIA7.8%

ImportsUNITED STATES → India$92.3K BRAZIL → India$80.0K

#1 Supplier: HETERO LABS

Ritonavir Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Ritonavir to the World

Between 2022 and 2026, India exported $340.6M worth of ritonavir across 1,555 verified shipments to 155 countries — covering 79% of world markets in the Antiviral & HIV Medications segment. The largest destination is BELGIUM (51.5%). HETERO LABS LIMITED leads with a 56.9% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Ritonavir export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Ritonavir export data snapshot — $340.6M · 84 exporters · 155 countriesTransData Nexus · Indian Customs Data

Top Ritonavir Exporters from India

84 active exporters · Ranked by export value

View all 84 →

Top Ritonavir Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	HETERO LABS LIMITED	$193.8M	494	81	56.9%
2	MYLAN LABORATORIES LIMITED

Top Countries Importing Ritonavir from India

155 destination markets · Ranked by import value

All 155 countries →

Top Countries Importing Ritonavir from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	BELGIUM	$175.4M	51.5%
2	INDONESIA	$26.6M	7.8%
3	VIETNAM	$21.3M	6.3%
4	RWANDA	$16.5M	4.9%
5	SOUTH AFRICA	$12.7M	3.7%
6	KENYA	$11.9M	3.5%
7	TANZANIA	$8.5M	2.5%
8	THAILAND	$6.9M	2.0%
9	ETHIOPIA	$6.3M	1.8%
10	NIGERIA	$4.6M	1.4%

BELGIUM is India's largest ritonavir export destination, absorbing 51.5% of total exports worth $175.4M. The top 5 importing countries — BELGIUM, INDONESIA, VIETNAM, RWANDA, SOUTH AFRICA — together account for 74.1% of India's total ritonavir export value. The remaining 150 destination countries collectively receive the other 25.9%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Ritonavir to India?

14 origin countries · Total import value: $226.4K

India imports ritonavir from 14 countries with a combined import value of $226.4K. The largest supplier is UNITED STATES ($92.3K, 43 shipments), followed by BRAZIL and GERMANY. All values are from Indian Customs (DGFT) import records.

Countries Supplying Ritonavir to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$92.3K	43	40.8%
2	BRAZIL	$80.0K	8	35.3%
3	GERMANY	$14.2K	4	6.3%
4	SOUTH KOREA	$13.2K	2	5.8%
5	UNITED KINGDOM	$10.7K	4	4.7%
6	CHINA	$8.3K	4	3.7%
7	PUERTO RICO	$2.0K	1	0.9%
8	CYPRUS	$1.8K	1	0.8%
9	SINGAPORE	$1.7K	2	0.8%
10	NETHERLANDS	$982	1	0.4%

Showing top 10 of 14 origin countries

UNITED STATES is the largest supplier of ritonavir to India, accounting for 40.8% of total import value. The top 5 origin countries — UNITED STATES, BRAZIL, GERMANY, SOUTH KOREA, UNITED KINGDOM — together supply 93.0% of India's ritonavir imports. Click any country to see detailed supplier and buyer data for that import corridor.

Ritonavir — Export Intelligence Video

Visual overview of India's ritonavir import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's ritonavir pharmaceutical import and export market — $340.6M in total trade, 84 verified manufacturers, and 155 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Ritonavir

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, Ritonavir is approved under multiple Abbreviated New Drug Applications (ANDAs), as listed in the FDA's Orange Book. These approvals facilitate the marketing of generic versions, enhancing accessibility and affordability. As of March 2026, there are no active FDA import alerts specifically targeting Ritonavir, indicating compliance with U.S. regulatory standards. Given the presence of 84 active Indian exporters, it is imperative for each to adhere strictly to FDA regulations to maintain market access.

2EU & UK Regulatory Framework

The European Medicines Agency (EMA) has granted marketing authorizations for Ritonavir-containing products, such as Norvir, indicated for the treatment of HIV-1 infections in combination with other antiretroviral agents. On 18 September 2025, the EMA's Committee for Medicinal Products for Human Use (CHMP) recommended updates to Norvir's indications and contraindications to enhance patient safety and therapeutic efficacy. Manufacturers exporting to the EU and UK must comply with Good Manufacturing Practice (GMP) requirements, ensuring product quality and safety.

3WHO Essential Medicines & Global Standards

Ritonavir is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in global health. The WHO Prequalification Programme has prequalified Ritonavir active pharmaceutical ingredients (APIs) from manufacturers such as Shanghai Desano Chemical Pharmaceutical Co Ltd (prequalified on 25 November 2014) and Laurus Labs Limited (prequalified on 7 December 2021). Compliance with international pharmacopoeia standards, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), is essential for market acceptance.

4India Regulatory Classification

In India, Ritonavir is classified under Schedule H of the Drugs and Cosmetics Act, requiring a prescription for dispensing. The National Pharmaceutical Pricing Authority (NPPA) regulates its pricing under the Drug Price Control Order (DPCO). As of March 2026, the ceiling price for Ritonavir is set to ensure affordability. Exporters must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for compliance with export regulations.

5Patent & Exclusivity Status

The initial patent for Ritonavir was filed in July 1994 by Abbott Laboratories. Subsequent patents have covered various formulations and manufacturing processes. As of March 2026, many of these patents have expired, allowing for increased generic competition and market diversification.

6Recent Industry Developments

In September 2025, the EMA's CHMP recommended updates to the marketing authorization for Norvir, reflecting ongoing efforts to optimize Ritonavir's therapeutic use. In December 2021, Laurus Labs Limited's Ritonavir API was prequalified by the WHO, enhancing its credibility in global markets. In August 2023, the European Commission withdrew the marketing authorization for Invirase (saquinavir), another protease inhibitor, due to commercial reasons, potentially impacting the competitive landscape for Ritonavir. In January 2022, the EMA recommended conditional marketing authorization for Paxlovid, a combination of nirmatrelvir and ritonavir, for the treatment of COVID-19, expanding Ritonavir's therapeutic applications. In November 2025, the European Commission withdrew the marketing authorization for Telzir (fosamprenavir), another protease inhibitor, due to commercial reasons, further influencing the market dynamics for Ritonavir.

These developments underscore the dynamic regulatory and market environment surrounding Ritonavir, necessitating continuous monitoring and compliance by exporters to maintain and expand their market presence.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Ritonavir

Retail & reference prices across 9 markets vs. India FOB export price of $20.57/unit

Global Price Benchmark for Ritonavir across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	N/A	USD	Pricing information for Ritonavir 100 mg tablets is not publicly disclosed by the FDA.
United Kingdom	N/A	GBP	The NHS Drug Tariff does not list specific prices for Ritonavir 100 mg tablets.
Germany	N/A	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) does not provide public pricing data for Ritonavir 100 mg tablets.
Australia	N/A	AUD

Supply Chain Risk Assessment — Ritonavir

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Ritonavir, heavily relies on Key Starting Materials (KSMs) sourced from China. According to the U.S. Pharmacopeia, 58% of KSMs used for U.S.-approved active pharmaceutical ingredients are solely sourced from a single country, highlighting a significant vulnerability in the supply chain. This dependency exposes the supply chain to risks associated with geopolitical tensions, trade restrictions, and production disruptions in China.

Recent geopolitical events have further exacerbated these vulnerabilities. In March 2026, the closure of the Strait of Hormuz disrupted the transportation of petrochemical feedstocks essential for pharmaceutical manufacturing. This disruption led to increased production costs and logistical challenges, affecting the availability and affordability of APIs like Ritonavir.

2Supplier Concentration & Single-Source Risk

The export market for Ritonavir is highly concentrated, with the top five Indian exporters accounting for 96.9% of total exports. HETERO LABS LIMITED alone holds a 56.9% share, exporting $193.8 million worth of Ritonavir. This high concentration poses a significant risk, as any operational or regulatory issues affecting these key suppliers could disrupt the global supply of Ritonavir.

To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme, aiming to boost domestic manufacturing of critical APIs and reduce dependency on imports. However, the effectiveness of this initiative in diversifying the supplier base for Ritonavir remains to be seen.

Access Complete Ritonavir Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 1,555 transactions across 155 markets.

Request Demo View Pricing

Frequently Asked Questions — Ritonavir Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top ritonavir exporters from India?

The leading ritonavir exporters from India are HETERO LABS LIMITED, MYLAN LABORATORIES LIMITED, CIPLA LIMITED, and 9 others. HETERO LABS LIMITED leads with 56.9% market share ($193.8M). The top 5 suppliers together control 96.9% of total export value.

What is the total export value of ritonavir from India?

The total export value of ritonavir from India is $340.6M, recorded across 1,555 shipments from 84 active exporters to 155 countries. The average shipment value is $219.0K.

Which countries import ritonavir from India?

India exports ritonavir to 155 countries. The top importing countries are BELGIUM (51.5%), INDONESIA (7.8%), VIETNAM (6.3%), RWANDA (4.9%), SOUTH AFRICA (3.7%), which together account for 74.1% of total export value.

What is the HS code for ritonavir exports from India?

The primary HS code for ritonavir exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Ritonavir

Ritonavir

Top Ritonavir Exporters from India

Top Countries Importing Ritonavir from India

Who Supplies Ritonavir to India?

Quick Facts

Related Antiviral & HIV Medications

Related Analysis

Need Details?

Ritonavir — Export Intelligence Video

Regulatory Landscape — Ritonavir

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Ritonavir

Supply Chain Risk Assessment — Ritonavir

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Ritonavir Trade Intelligence

Frequently Asked Questions — Ritonavir Exports from India

Who are the top ritonavir exporters from India?

What is the total export value of ritonavir from India?

Which countries import ritonavir from India?

What is the HS code for ritonavir exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of ritonavir exports from India?

Which ports handle ritonavir exports from India?

Why is India a leading exporter of ritonavir?

What certifications do Indian ritonavir exporters need?

How many buyers import ritonavir from India?

What is the market share of the top ritonavir exporter from India?

Analysis Methodology